Back to CLDX
Point72 Asset Management, L.P. → CLDX
Point72 Asset Management, L.P. CLDX Position History
Celldex Therapeutics, Inc.
Quarters held
19
Latest value
$37K
Q2 2026
Peak value
$109.3M
First seen
Q2 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2023 | $40.2M |
| Q3 2023 | $36.9M |
| Q4 2023 | $109.3M |
| Q1 2024 | $53.9M |
| Q2 2024 | $71.7M |
| Q2 2024 | $71.7M |
| Q2 2024 | $71.7M |
| Q3 2024 | $53.3M |
| Q3 2024 | $3.4M |
| Q4 2024 | $63.6M |
| Q1 2025 | $47.6M |
| Q1 2025 | $47.6M |
| Q2 2025 | $57M |
| Q3 2025 | $100.7M |
| Q4 2025 | $47.8M |
| Q1 2026 | $102.5M |
| Q2 2026 | $4.4M |
| Q2 2026 | $45K |
| Q2 2026 | $37K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $37K | 1.0K | — | — |
| Q2 2026 | $45K | 1.2K | — | — |
| Q2 2026 | $4.4M | 117.2K | — | — |
| Q1 2026 | $102.5M | 3.23M | — | — |
| Q4 2025 | $47.8M | 1.76M | — | — |
| Q3 2025 | $100.7M | 3.89M | — | — |
| Q2 2025 | $57M | 2.80M | — | — |
| Q1 2025 | $47.6M | 2.62M | — | — |
| Q1 2025 | $47.6M | 2.62M | — | — |
| Q4 2024 | $63.6M | 2.52M | — | — |
| Q3 2024 | $3.4M | 100.0K | — | — |
| Q3 2024 | $53.3M | 1.57M | — | — |
| Q2 2024 | $71.7M | 1.94M | — | — |
| Q2 2024 | $71.7M | 1.94M | — | — |
| Q2 2024 | $71.7M | 1.94M | — | — |
| Q1 2024 | $53.9M | 1.28M | — | — |
| Q4 2023 | $109.3M | 2.76M | — | — |
| Q3 2023 | $36.9M | 1.34M | — | — |
| Q2 2023 | $40.2M | 1.18M | — | — |
Other funds holding CLDX
$145.1M
$145.1M
$88.9M
$69.3M
$50.8M